Skip to main content
. 2012 Dec 31;2012:257597. doi: 10.1155/2012/257597

Table 3.

Description of the sample and the health conditions of the mothers participating in the 2004 Birth Cohort (N), prevalence (P%) and adjusted analyses of the use of medicines during pregnancy considering all medicines and the medicines with unknown fetal risk used. Birth Cohort of Pelotas, RS 2004.

N Use of medicines (total) Use of medicines with unknown fetal risk
Characteristic Adjusted analyses Adjusted analyses
P% PR (IC 95%) P value P% PR (IC 95%) P value
Total of participants 4,189 92.7 52.5
Age 0,062 0.076
 <20 796 90.8 1.00 43.6 1.00
 20 to 29 2,085 93.1 1.58 (1.03–2.43) 53.2 1.09 (0.90–1.32)
 30 to 39 1,170 92.9 2.01 (1.19–3.38) 56.9 1.31 (1.05–1.64)
 40 or more 136 94.1 2.35 (0.83–6.62) 55.1 1.18 (0.76–1.84)
Skin color 0,08 <0.001
 White 2,555 93.8 1.31 (0.97–1.78) 57.7 1.36 (1.17–1.58)
 Non-white 1,586 90.9 1.00 44.1 1.00
Education in years 0.026 <0.001
 0 to 4 647 87.3 1.00 32.8 1.00
 5 to 8 1,711 91.6 1.50 (1.02–2.23) 47.0 1.70 (1.35–2.13)
 9 to 11 1,396 95.1 1.90 (1.19–3.03) 62.7 2.57 (2.01–3.30)
 12 or more 435 97.2 2.66 (1.22–5.79) 70.6 2.74 (1.95–3.85)
Marital status 0.064 0.92
 With the baby's father 3,502 93.1 1.44 (0.98–2.11) 53.5 0.99 (0.81–1.21)
 Without 687 90.5 1.00 47.0 1.00
Income per capita 0.09 <0.001
 1st quintile 830 88.4 1.00 38.2 1.00
 2nd quintile 834 89.2 0.83 (0.55–1.25) 41.7 1.03 (0.82–1,30)
 3rd quintile 886 94.2 1,48 (0.93–2.36) 52.7 1.29 (1.03–1.62)
 4th quintile 849 94.7 1.11 (0.68–1.82) 61.1 1.79 (1.41–2.27)
 5th quintile 790 96.8 1.55 (0.81–2.95) 69.2 1.94 (1.47–2.55)
Parity 0.025 0.52
 primipara 1,658 94.8 2.45 (1.34–4.46) 55.9 1.12 (0.81–1.56)
 1 or 2 1,086 93.0 1.65 (0.96–2.82) 54.8 1.06 (0.78–1.45)
 3 or 4 1,026 91.6 1.36 (0.83–2.23) 48.6 0.95 (0.70–1.27)
 5 or more 419 86.2 1.00 42.2 1.00
Prenatal consultation 0.004 0.001
 <6 689 86.6 1.00 36.0 1.00
 6 or more 3,250 94.9 1.65 (1.18–2.32) 56.8 1.39 (1.14–1.70)
Start of prenatal care 0.70 0.32
 Before the 20th week 3,765 94.0 1.10 (0.68–1.80) 54.8 1.18 (0.85–1.64)
 After the 20th week 283 84.8 1.00 31.4 1.00
Hospitalization
 No 3,722 91.9 1.00 0.002 50.9 1.00 0.05
 Yes 467 98.9 6.50 (1.99–21.21) 64.7 1.28 (1.00–1.62)
High Blood Pressure 0.012 0.87
 No 3,189 92.3 1.00 52.6 1.00
 Yes 992 94.0 1.60 (1.11–2.31) 52.3 0.90 (0.59–1.37)
Diabetes 0.76 0.63
 No 4,062 92.6 1.00 52.4 1.00
 Yes 124 96.0 0.86 (0.32–2.30) 56.4 0.90 (0.59–1.37)
Depression 0.034 <0.001
 No 3,138 92.1 1.00 51.0 1.00
 Yes 1049 94.3 1.49 (1.03–2.16) 56.9 1.38 (1.16–1.64)
Anemia <0.001 <0.001
 No 1,402 83.0 1.00 42.7 1.00
 Yes 2756 97.8 10.79 (7.68–15.16) 57.7 1.53 (1.31–1.78)
Threat of abortion 0.15 <0.001
 No 3,736 92.2 1.00 50.0 1.00
 Yes 449 96.4 1.55 (0.85–2.83) 73.0 2.40 (1.84–3.11)
Threat of premature labor <0.001 <0.001
 Não 3,416 91.7 1.00 48.0 1.00
 Sim 771 97.0 2.72 (1.57–4.73) 72.5 2.65 (2.15–3.27)
Urinary Infection <0.001 0.012
 Não 2,623 89,8 1.00 52.5 1.00
 Sim 1,552 97.7 5.53 (3.58–8.54) 52.5 0.82 (0.71–0.96)

*Chi square test; **1st quintile relates to the most deprived quintile ***PR: prevalence ratio.